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Artemisia annua L. (Asteraceae) is native to China, now naturalised inmany other countries, well known as the source of the unique
sesquiterpene endoperoxide lactone artemisinin, and used in the treatment of the chloroquine-resistant and cerebral malaria.
The essential oil is rich in mono- and sesquiterpenes and represents a by-product with medicinal properties. Besides significant
variations in its percentage and composition have been reported (major constituents can be camphor (up to 48%), germacrene
D (up to 18.9%), artemisia ketone (up to 68%), and 1,8 cineole (up to 51.5%)), the oil has been subjected to numerous studies
supporting exciting antibacterial and antifungal activities. Both gram-positive bacteria (Enterococcus, Streptococcus, Staphylococcus,
Bacillus, and Listeria spp.), and gram-negative bacteria (Escherichia, Shigella, Salmonella,Haemophilus,Klebsiella, and Pseudomonas
spp.) and other microorganisms (Candida, Saccharomyces, andAspergillus spp.) have been investigated. However, the experimental
studies performed to date used different methods and diverse microorganisms; as a consequence, a comparative analysis on a
quantitative basis is very difficult. The aim of this review is to sum up data on antimicrobial activity of A. annua essential oil and
its major components to facilitate future approach of microbiological studies in this field.
1. Introduction
Artemisia annua L., a plant belonging to the Asteraceae
family, is an annual herb native to China and it grows
naturally as a part of steppe vegetation in northern parts of
Chatar and Suiyan province in China at 1,000–1,500m above
sea level. This plant can grow up to 2.4m tall. The stem is
cylindrical and branched. Leaves are alternate, dark green, or
brownish green. Odour is characteristic and aromatic while
the taste is bitter. It is characterized by large panicles of
small globulous capitulums (2-3mm diameter), with whitish
involucres, and by pinnatisect leaves which disappear after
the blooming period, characterised by small (1-2mm) pale
yellow flowers having a pleasant odour (Figure 1). The Chi-
nese name of the plant is Qinghao (or Qing Hao or Ching-
hao which means green herb). Other names are wormwood,
Chinese wormwood, sweet wormwood, annual wormwood,
annual sagewort, annual mugwort, and sweet sagewort. In
the USA, it is well known as sweet Annie because after
its introduction in the nineteenth century it was used as a
preservative and flavouring and its aromatic wreath made a
nice addition to potpourris and sachets for linens and the
essential oil obtained from the flowering tops is used in the
flavouring of vermouth [1]. The plant is now naturalised in
many other countries such as Australia, Argentina, Brazil,
Bulgaria, France, Hungary, Italy, Spain, Romania, the United
States, and the former Yugoslavia [2].
Due to the presence of the unique sesquiterpene endoper-
oxide lactone artemisinin (Qinghaosu), one of the most
important plant-derived drug in the treatment of the
chloroquine-resistant and cerebral malarias, the plant is
cropped on a large scale in China, Vietnam, Turkey, Iran,
Afghanistan, and Australia. In India, it is cultivated on an
experimental basis in the Himalayan regions, as well as
temperate and subtropical conditions [3].
The essential oil which is rich in mono- and sesquiter-
penes represents another source of potential commercial
value [4]. Besides significant variations in its percentage and
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Figure 1: Picture ofA. annuaflowers (fromhttp://upload.wikimedia
.org/wikipedia/commons/5/59/Artemisia annua detail.jpeg).
composition have been reported, it has been successfully
subjected to numerous studies which mainly concern the
antibacterial and antifungal activities. Diverse experimental
studies have been reported to date using different methods
and testing different microorganisms; therefore, a compara-
tive analysis on a quantitative basis is very difficult. The aim
of our review is to sum up data on antimicrobial activity ofA.
annua volatiles and its major components to facilitate future
approach of microbiological experimental in this field.
2. Plant Distribution and Yield of the Volatiles
Essential (volatile) oil of A. annua can reach yields of
85 kg/ha. It is synthesised by secretory cells, especially of the
uppermost foliar portion of the plant (top 1/3 of growth at
maturity) which contains almost double number if compared
with the lower leaves. It is reported that 35% of the mature
leaf surface is covered with capitate glands which contain the
terpenoidic volatile constituents. Essential oil from A. annua
is distributed, with 36% of the total from the upper third of
the foliage, 47% from the middle third, and 17% from the
lower third, with only trace amounts in the main stem side
shoots and roots.The yield of the oil generally ranges between
0.3 and 0.4% but it can reach 4.0% (V/W) from selected
genotypes. Several studies have permitted the conclusion that
A. annua crop could be harvested much before onset of
flowering for obtaining high yields of artemisinin and the
crop must be allowed to attain maturity to obtain high yields
of the essential oil [5, 6].
Yield (herbage and essential oil content) can be increased
with added nitrogen and the greatest growth was obtained
with 67 kgN/ha. Increasing density of plants tended to
increase essential oil production on an area basis, but the
highest essential oil yields (85 kg oil/ha) were achieved by the
intermediate density at 55,555 plants/ha receiving 67 kgN/ha.
Finally the planting date and harvest time can influence the
maximum concentration of the produced essential oil [6].
3. Chemical Profile of the Essential Oil
The essential oil, generally obtained by hydrodistillation of
the flowering tops, analysed with GC-MS, revealed a great
variability both in the qualitative and quantitative composi-
tion.
Chemical profile is generally influenced by the harvesting
season, fertilizer and the pH of soils, the choice and stage
of drying conditions, the geographic location, chemotype or
subspecies, and choice of part plant or genotype or extraction
method. In Table 1, the main constituents (>4%) of the
investigated samples are reported.
Analysis of A. annua essential oils revealed the presence
of mainly monoterpenoids and sesquiterpenes and the pro-
files showed great differences in the three main components,
artemisia ketone, 1,8-cineole, and camphor, depending on the
global phytogeographic origin. Oils can be grouped into the
following:
(i) Vietnamese oil with 3.3–21.8% camphor and 0.3–
18.9% germacrene D,
(ii) Chinese oil with high content of artemisia ketone
(64%),
(iii) Indian oil with 11.5–58.8% of artemisia ketone,
(iv) French oil with 2.8–55% artemisia ketone, 1.2–11.6%
1,8-cineole, and 15% germacrene D,
(v) North American oil with 35.7–68% artemisia ketone
and 22.8–31.5% 1,8-cineole,
(vi) Iranian oil with 48% camphor and 9.4% 1,8-cineole.
The presence of volatile oil is also reported in fruits
and roots. Sesquiterpenes are the most abundant chemicals
identified in the essential oil of the fruits; in particular,
caryophyllene oxide (9.0%), caryophyllene (6.9%), (E)-𝛽-
farnesene (8.2%), and germacrene D (4.0%) are identified.
However, only 52% of the total components were identified
[7].
Upon hydrodistillation, the dried roots of Artemisia
annua L. cultivar Jwarharti, a pleasantly fragrant essential
oil, have been obtained with a yield of 0.25%. The oil was
rich in sesquiterpenes and oxygenated sesquiterpenes and
had cis-arteannuic alcohol (25.9%), (E)-𝛽-farnesene (6.7%),
𝛽-maaliene (6.3%), 𝛽-caryophyllene (5.5%), caryophyllene
oxide (4.4%), and 2-phenylbenzaldehyde (3.5%) as its major
components [8].
Recently, the analysis of aromatic waters, obtained from
plants collected at full blooming, showed the presence,
among others, of camphor (27.7%), 1,8-cineole (14%),
artemisia ketone (10.1%), 𝛼-terpineol (6.1%), trans-
pinocarveol (5.4%), and artemisia alcohol (2%). From
plants at the preflowering stage, aromatic waters gave
camphor (30.7%), 1,8-cineole (12.8%), artemisia alcohol
(11.4%), artemisia ketone (9.5%), alpha-terpineol (5.8%),
and trans-pinocarveol (3.0%) as the main constituents. The
qualitative and quantitative profiles of the two aromatic
waters were similar [5].
4. Antimicrobial Activities of the Essential Oils
The essential oil of Artemisia annua has been the subject
of numerous studies to test the antibacterial and antifungal
activity. Tests were carried out both on the whole oil
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Table 1: Compounds (>4%) isolated from essential oil of Artemisia
annua L.
Compound Country % Reference
Artemisia alcohol
China (Cult) 7.5 [20]
USA-CA 5.2 [21]
Serbia 4.8 [10]
Artemisia ketone
Not stated 38.0 [22]
France 52.5 [23]
Serbia 35.7 [10]
Egypt 13.9 [15]
China 2.21 [11]
Bosnia 30.7 [9]
USA-CA 35.7 [24]
China (Cult) 63.9 [20]
USA-IN 68.5 [25]
England 61.0 [26]
Vietnam 0.1–4.4 [27]
Indian (Cult) 58.8 [28]
India (Cult) 11.5 [29]
Turkey 22 [19]
Borneol
Not stated 20.0 [22]
England 7.0 [26]
China (Cult) 15.9 [30]
Camphene Iran 7 [13]
Camphene hydrate USA-IN 12.0 [25]
Camphor
Vietnam 21.8 [3]
Serbia 4.2 [10]
Egypt 5.08 [15]
France 27.5 [23]
China (Cult) 21.8 [20]
Vietnam (Cult) 3.3 [20]
Bosnia 15.8 [9]
Iran 1.92 [14]
Italy 17.6 [5]
Indian (Cult) 15.75 [28]
India (Cult) 8.4 [29]
France 43.5 [12]
Iran 48 [13]
Turkey 31 [19]
Trans-Cariophyllene Egypt 7.73 [15]
𝛽-Caryo phyllene
Italy 9.0 [5]
Vietnam (Cult) 5.6 [20]
Vietnam 3.3–8.6 [27]
China (Cult) 5.98 [30]
India (Cult) 12.2 [29]
France 8.9 [12]
Caryophyllene oxide China 5.13 [11]
Chrysanthenone Vietnam 1.1–7.3 [27]
India (Cult) 10.19 [28]
Table 1: Continued.
Compound Country % Reference
1,8-Cineol
France 11.66 [23]
Serbia 5.5 [10]
Egypt 8.13 [15]
Bosnia 4.8 [9]
USA-IN 22.8 [25]
USA-CA 31.5 [21]
Iran 9.4 [13]
Iran 11.4 [14]
Turkey 10 [19]
𝛽-Farnesene
Italy 10.2 [5]
Vietnam 1.1–12.8 [27]
Egypt 5.32 [15]
China (Cult) 12.9 [30]
Germacrene D
Vietnam (Cult) 18.3 [20]
Italy 21.2 [5]
Vietnam 0.3–18.9 [27]
China (Cult) 10.9 [30]
France 15.6 [12]
𝛼-Guaiene China (Cult) 4.7 [20]
Linalool Vietnam 0.1–4.2 [27]
Iran 8.1 [14]
Linalool acetate England 10.0 [22]
Myrcene
China (Cult) 5.1 [20]
USA-CA 4.6 [21]
Vietnam 0.1–8.5 [27]
𝛼-Pinene
USA-CA 11.2 [21]
USA-IN 16.0 [25]
Serbia 16.5 [10]
(Trans)-Pinocarveol France 10.9 [12]
Serbia 4.8 [10]
Sabinene France 9.4 [12]
Spathulenol Iran 4.97 [14]
Iran 4.9 [13]
(Table 2) and on its principal components such as camphor,
1,8-cineol, 𝛼-pinene, and artemisia ketone (Table 3).
The main gram-positive bacteria tested with A. annua
volatiles obtained by hydrodistillation were Staphylococcus
aureus [9–14], Enterococcus hirae [12], Enterococcus faecalis
[14], Streptococcus pneumoniae, Micrococcus luteus [9],
Bacillus cereus [14], Sarcina lutea [10], Bacillus subtilis
[9, 11], Bacillus thuringiensis [11], Bacillus spp. [14], and
Listeria innocua [15]. The gram-negative Escherichia coli
[9, 11–14], Escherichia coli UPEC-Uropathogenic [14],
Escherichia coli ETEC-Enterotoxigenic [16], Escherichia
coli EPEC-Enteropathogenic [16], Escherichia coli EIEC-
Enteroinvasive [16], Escherichia coli STEC-Shiga-toxin
producer [16], Shigella sp. [10], Salmonella enteritidis [10],
Klebsiella pneumoniae [10], Haemophilus influenzae [9], and
Pseudomonas aeruginosa [9, 13, 14] were tested. Some strains
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Table 2: Tests carried out on the whole oil.
Bacterial strains Agar diskdiffusion Concentration Reference MIC mg/mL Reference MBC mg/mL Reference
Gram-positive
S. aureus Not active [12]
Active 32 [13]
Active 5.00% [11] Active 0.0156–0.0313 [11]
Active 10mg/mL [9]
Active 5.0–10.0 [10] Low activity >20.0–10.0 [10]
Active 10mg/mL [14] Active 0.031 [14] Active 0.031 [14]
E. hirae Active 0.1mg/mL [12]
E. faecalis Active [9]
Active 10mg/mL [14] Active 0.026 [14] Active 0.031 [14]
S. pneumoniae Active 10mg/mL [9]
M. luteus Not active [9]
B. cereus Active 10mg/mL [14] Active 0.053 [14] Active 0.055 [14]
Low activity 20 [10] Low activity 20 [10]
B. subtilis Active 5.00% [11] Active 0.00781-0.00781 [11]
Active 10mg/mL [9]
B. thuringensis Active 5.00% [11] Active 0.0313–0.0156 [11]
B. sp. Active 10mg/mL [14] Active 0.026 [14] Active 0.053 [14]
L. innocua Not active [15]
Sarcina lutea Active 2.5 [10] Active 2.5 [10]
Gram-negative
E. coli Not active [12]
Active 64 [13]
Active 5.00% [11] Active 0.0313-0.0313 [11]
Active 10mg/mL [9]
Low activity 20 [10] Low activity 20 [10]
Active 5mg/mL [14] Active 0.017 [14] Active 0.024 [14]
UPEC Active 5mg/mL [14] Active 0.026 [14] Active 0.031 [14]
Shigella sp. Low activity 20 [10] Low activity 20 [10]
S. enteritidis Active 5 [10] Low activity 20 [10]
K. pneumoniae Low activity 20 [10] Low activity 20 [10]
H. influenzae Active 10mg/mL [9]
P. aeruginosa Not active [13]
Active 10mg/mL [9]
Active 10mg/mL [14] Active 0.025 [14] Active 0.053 [14]
Fungal strains Agar diskdiffusion Concentration Reference MIC mg/mL Reference MFC mg/mL Reference
C. albicans Active 0.2mg/mL [12]
Active 2 [13]
Low activity 20 [10] Not active >20 [10]
C. krusei Active 10mg/mL [9]
S. cerevisiae Active 0.2mg/mL [12]
Active 2 [13]
A. fumigatus Active 5 [10] Active 5 [10]
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of yeasts including Candida albicans [10, 12, 13], Candida
krusei [9], and Saccharomyces cerevisiae [12, 13] and molds
like Aspergillus fumigatus [10] were also tested (Table 2).
The main gram-positive bacteria tested with methanol,
chloroform, ethanol, hexane, and petroleum ether extracts
of A. annua were Staphylococcus aureus [14, 17], Enterococcus
faecalis [14], Micrococcus luteus [17], Bacillus cereus [14, 17],
Bacillus subtilis [17], Bacillus pumilus [17], and Bacillus sp.
[14]. The gram-negative Escherichia coli [14, 17], Escherichia
coli UPEC [14], Salmonella typhi [14, 17], and Pseudomonas
aeruginosa [14, 17] were tested.
In addition, several single main components were inves-
tigated (Table 3), including 𝛼-terpineol [18] tested on C.
albicans, C. glabrata, C. dubliniensis, C. guilliermondii, C.
krusei, C. parapsilosis, and C. tropicalis; artemisia ketone, 𝛼-
pinene, 1,8-cineole, and camphor [10] tested on C. albicans,
B. cereus, S. aureus, S. lutea, E. coli, K. pneumoniae, Ps.
aeruginosa, S. enteritidis, Shigella sp., and A. fumigatus.
The antifungal activity of the essential oil was also
evaluated against economically important foliar and soil-
borne fungal pathogens of tomato.The essential oil was active
against Sclerotinia sclerotiorum, Botrytis cinerea, Phytoph-
thora infestans, and Verticillim dahliae [19].
Different methods were used to evaluate the antibacterial
and antifungal properties and included agar disk diffusion
method [9, 11, 14, 17], minimal inhibition concentration
(MIC) [9, 10, 12–14, 16–18], minimal bacterial concentration
(MBC) [10, 14], andminimal fungicidal concentration (MFC)
[10, 18] as reported in Table 2.
The results related to agar disk diffusionmethod (Table 2)
show that some important pathogens are sensitive to A.
annua essential oil obtained by hydrodistillation. S. aureus,
S. pneumoniae, E. coli, UPEC, H. influenzae, P. aeruginosa,
C. albicans, and C. krusei were inhibited by the action of the
oil. H. influenzae, S. pneumoniae, and C. krusei were more
sensitive; their inhibition zones diameters were >60, 50, and
30mm, respectively. Satisfactory results were also achieved
with genusBacillus. On the contrary,M. luteus and L. innocua
were resistant to this essential oil. Since the use of agar
disk diffusion method is limited by the hydrophobic nature
of most essential oils and plant extracts components that
prevents their uniform diffusion through the agar medium,
the most authors report the results obtained with MIC and
MBC methods.
However, from the literature it is observed that the results
obtained by agar disk diffusion method were confirmed by
the liquid medium methods (MBC and MIC). At present
there is no complete agreement on the concentration of
the extracts to be considered active or inactive. Duarte and
coworkers [16] proposed a classification to be applied to
the extracts based on MIC values; this author considers
MIC up to 500𝜇g/mL as strong inhibitors, MIC between
600 and 1500𝜇g/mL as moderate inhibitors, and MIC above
1600 𝜇g/mL as weak inhibitors. In recent years, many dif-
ferent microbial species of medical interest have been tested
from which emerged encouraging results except in the case
of E. coli with special pathogenic characters (ETEC, EPEC,
EIEC, and STEC) sensitive only at high concentrations of the
extracts.
As concerns the results obtained against fungal strains,
the data are rather limited. The results are contrasted against
C. albicans but have to be more explored, while data related
to A. fumigatus and C. krusei are encouraging.
Further studies have been performed with the main
components present in A. annua essential oil (see Table 3).
These studies show that artemisia ketone is the component
of the oil that has the greatest antimicrobial activity; in
fact, it always turns out to be effective against bacteria and
some fungi (C. albicans and A. fumigatus) at very low con-
centrations (range 0.07–10mg/mL). The other compounds
tested in the studies have produced variable results; however,
it should be emphasized the fact that all the compounds
tested by liquid methods were active (range 1.25–5mg/mL)
against A. fumigatus, a dangerous microorganism frequently
responsible for nosocomial infections in immunosuppressed
subjects.
5. Concluding Remarks
During the last decade several authors have evaluated the
antimicrobial activity of Artemisia annua and some of its
main components.The composition of the essential oil shows
great differences in the three main characteristic compo-
nents, namely, artemisia ketone, 1,8-cineole, and camphor,
depending on the global phytogeographic origin. Besides the
different chemical profiles, artemisia essential oil has revealed
strong antimicrobial properties towards numerous bacterial
strains, both gram-positive and gram-negative, and diverse
fungal strains, including many pathogens. Biological effects
are the result of a synergism of all molecules contained in
an essential oil, even if it is possible that the activity of the
main components is modulated by other minor molecules,
but the activity of the isolated constituents is also remark-
able. Artemisia annua volatile constituents appear to be a
resource of many biologically active compounds which will
hopefully give new economically important by-product. The
good results obtained encourage further researches aiming
at a possible application of these substances in food and
pharmaceutical and cosmetology fields.
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